A PEG-lipid-free COVID-19 mRNA vaccine triggers robust immune responses in mice.

Li, Min; Huang, Yixuan; Wu, Jiacai; Li, Sanpeng; Mei, Miao; Chen, Haixia; Wang, Ning; Wu, Weigang; Zhou, Boping; Tan, Xu; Li, Bin

Li, Min; Huang, Yixuan; Wu, Jiacai; Li, Sanpeng; Mei, Miao; Chen, Haixia; Wang, Ning; Wu, Weigang; Zhou, Boping; Tan, Xu; Li, Bin.

Afiliación

Li M; Department of Infectious Disease, Shenzhen People's Hospital, The First Affiliated Hospital of Southern University of Science and Technology & The Second Clinical Medical College of Jinan University, Shenzhen 518020, China. libin@mail.sustech.edu.cn.
Huang Y; Department of Infectious Disease, Shenzhen People's Hospital, The First Affiliated Hospital of Southern University of Science and Technology & The Second Clinical Medical College of Jinan University, Shenzhen 518020, China. libin@mail.sustech.edu.cn.
Wu J; Department of Infectious Disease, Shenzhen People's Hospital, The First Affiliated Hospital of Southern University of Science and Technology & The Second Clinical Medical College of Jinan University, Shenzhen 518020, China. libin@mail.sustech.edu.cn.
Li S; School of Medicine, Southern University of Science and Technology, Shenzhen, 518055, China.
Mei M; Department of Infectious Disease, Shenzhen People's Hospital, The First Affiliated Hospital of Southern University of Science and Technology & The Second Clinical Medical College of Jinan University, Shenzhen 518020, China. libin@mail.sustech.edu.cn.
Chen H; School of Pharmaceutical Sciences, Tsinghua-Peking Center for Life Sciences, Tsinghua University, Beijing 100084, China.
Wang N; Department of Clinical Laboratory, Shenzhen People's Hospital, The First Affiliated Hospital of Southern University of Science and Technology & The Second Clinical Medical College of Jinan University, Shenzhen 518020, China.
Wu W; Department of Infectious Disease, Shenzhen People's Hospital, The First Affiliated Hospital of Southern University of Science and Technology & The Second Clinical Medical College of Jinan University, Shenzhen 518020, China. libin@mail.sustech.edu.cn.
Zhou B; School of Medicine, Southern University of Science and Technology, Shenzhen, 518055, China.
Tan X; Department of Infectious Disease, Shenzhen People's Hospital, The First Affiliated Hospital of Southern University of Science and Technology & The Second Clinical Medical College of Jinan University, Shenzhen 518020, China. libin@mail.sustech.edu.cn.
Li B; Department of Infectious Disease, Shenzhen People's Hospital, The First Affiliated Hospital of Southern University of Science and Technology & The Second Clinical Medical College of Jinan University, Shenzhen 518020, China. libin@mail.sustech.edu.cn.

Mater Horiz ; 10(2): 466-472, 2023 02 06.

Article en En | MEDLINE | ID: mdl-36468425

Asunto(s)

Vacunas contra la COVID-19; COVID-19; Animales; Humanos; Ratones; COVID-19/prevención & control; Pandemias; SARS-CoV-2; Vacunas de ARNm; Inmunidad; Mamíferos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Límite: Animals / Humans Idioma: En Revista: Mater Horiz Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google